Relay Therapeutics Inc. Common Stock vs Invesco Solar ETF — how do they compare? Relay Therapeutics Inc. Common Stock trades at $18.47 (market cap $3.82B), while Invesco Solar ETF trades at $43.44 (market cap $894.08M). The key difference: Relay Therapeutics Inc. Common Stock is far larger — about 4.3× Invesco Solar ETF's market cap, and Relay Therapeutics Inc. Common Stock is trading nearer its 52-week high, Invesco Solar ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Relay Therapeutics Inc. Common Stock for 0 Days and Invesco Solar ETF for 34 Days on average.
| RLAY | TAN | |
|---|---|---|
Market Cap | $3.82B | $894.08M |
Volume | 4,332,079 | 370,994 |
Sector | Health | Sector/Thematic |
52-Week High | $20.75 | $73.95 |
52-Week Low | $6.03 | $43.00 |
Typical Hold Time | 0 Days | 34 Days |
Enterprise Value | $2.93B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TAN (Invesco Solar ETF) is trading at $43.53, down 1.96% amid sector-wide pressure from high borrowing costs impacting solar project financing. Technical indicators show a bearish trend with moving averages signaling sell pressure, while oscillators remain neutral. The ETF faces headwinds from solar industry volatility, price deflation, and margin erosion, having underperformed the S&P 500 by 112% over five years according to Seeking Alpha analysis from August 2026.
Outlook remains challenging with persistent sector headwinds including interest rate sensitivity and market saturation risks. Investment opportunity exists in long-term renewable energy transition, but requires tolerance for high volatility and deeper drawdowns compared to traditional energy ETFs. Key risks include policy uncertainty, grid adaptation costs, and competitive pressure from broader clean energy alternatives.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →TAN is a thematic ETF that tracks the MAC Global Solar Energy Index. It provides targeted exposure to the global solar industry, including manufacturers of solar panels, installers, and component suppliers like Enphase and First Solar.
Read more on TAN →